首页> 外国专利> 5-hydroxymethyl-1,6-naphthyridin-2 (1H) -ones, alkanoatestre thereof, 5-methyl (or ethyl) -1,6-naphthyridin-2 (1H) -one-6-oxide as cardiotonic preparations and processes for the preparation of which

5-hydroxymethyl-1,6-naphthyridin-2 (1H) -ones, alkanoatestre thereof, 5-methyl (or ethyl) -1,6-naphthyridin-2 (1H) -one-6-oxide as cardiotonic preparations and processes for the preparation of which

机译:5-羟甲基-1,6-萘啶-2(1H)-,其链烷酸酯,5-甲基(或乙基)-1,6-萘吡啶-2(1H)-1-6氧化物的强心制剂及其制备方法的准备

摘要

4-R min -5-Q-1,6-naphthyridin-2(1H)-ones (1), where R min is hydrogen or methyl and Q is hydroxymethyl, 1-hydroxyethyl alkanoyloxymethyl or 1-alkanoyloxyethyl, are produced by first reacting 4-R min -5-acetyl (or n-propanoyl)-6[2-(dilower-alkylamino]-2(1H)-pyridinone (III) with hydroxylamine or salt thereof to produce 4-R min -5-Q min -1,6-naphthyridin-2(1H)-one-6-oxide (II), where R min is defined as above and Q min is methyl or ethyl; next reacting II with an alkanoic anhydride to produce I where Q is alkanoyloxymethyl or 1-alkanoyloxyethyl; and, then hydrolyzing said alkanoyloxymethyl or -ethyl compound to produce I where Q is hydroxymethyl or 1-hydroxyethyl. Also shown is the cardiotonic use of II and I where Q is hydroxymethyl, 1-hydroxyethyl or alkanoyloxymethyl.
机译:首先制备4-R min -5-Q-1,6-萘啶-2(1H)-(1),其中R min为氢或甲基,Q为羟甲基,生成1-羟乙基烷酰氧基甲基或1-烷酰氧基乙基。使4-R min -5-乙酰基(或正丙酰基)-6 [2-(二低级烷基氨基)-2(1H)-吡啶酮(III)与羟胺或其盐反应生成4-R min -5-Q min -1,6-萘啶-2(1H)-一6-氧化物(II),其中R min如上定义,Q min为甲基或乙基;然后将II与链烷酸酐反应生成I,其中Q为烷氧基氧基甲基或1-烷氧基氧基乙基;然后水解所述链烷氧基氧基甲基或-乙基化合物以产生I,其中Q为羟甲基或1-羟乙基;还显示II和I的强心用法,其中Q为羟甲基,1-羟乙基或烷酰氧基甲基。

著录项

  • 公开/公告号DK380284A

    专利类型

  • 公开/公告日1985-02-09

    原文格式PDF

  • 申请/专利权人 STERLING DRUG INC.;

    申请/专利号DK19840003802

  • 发明设计人 LESHER GEORGE YOHE;SINGH BALDEV;

    申请日1984-08-07

  • 分类号C07D;

  • 国家 DK

  • 入库时间 2022-08-22 08:17:01

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号